Alps Advisors Inc Ac Immune Sa Transaction History

Alps Advisors Inc

$14.5 Billion
Q2 2024

A detailed history of Alps Advisors Inc transactions in Ac Immune Sa stock. As of the latest transaction made, Alps Advisors Inc holds 77,376 shares of ACIU stock, worth $286,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares

77,376

Holding current value

$286,291

% of portfolio

0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$2.29 - $4.87 $177,191 - $376,821	77,376 New	77,376 $308,000
Q4 2021 Feb 09, 2022	SELL	$4.83 - $7.56 $430,063 - $673,142	-89,040 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.2 - $8.34 $41,261 - $55,502	-6,655 Reduced 6.95%	89,040 $597,000
Q2 2021 Aug 11, 2021	SELL	$6.04 - $8.37 $207,232 - $287,174	-34,310 Reduced 26.39%	95,695 $759,000
Q1 2021 May 07, 2021	BUY	$5.32 - $8.96 $643 - $1,084	121 Added 0.09%	130,005 $989,000
Q4 2020 Feb 03, 2021	BUY	$4.47 - $5.58 $580,581 - $724,752	129,884 New	129,884 $672,000
Q4 2019 Feb 07, 2020	SELL	$4.56 - $8.78 $614,396 - $1.18 Million	-134,736 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$4.8 - $5.89 $31,852 - $39,086	-6,636 Reduced 4.69%	134,736 $667,000
Q2 2019 Aug 07, 2019	SELL	$4.72 - $5.88 $100,701 - $125,449	-21,335 Reduced 13.11%	141,372 $785,000
Q1 2019 May 01, 2019	BUY	$3.65 - $11.68 $25,655 - $82,098	7,029 Added 4.52%	162,707 $822,000
Q4 2018 Feb 04, 2019	BUY	$7.35 - $11.7 $1.14 Million - $1.82 Million	155,678 New	155,678 $1.47 Million

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.6M

Call Options Held

163K

Put Options Held

37.6K

Bvf Inc San Francisco, CA

18.8M
Shares

$69.7 Million
2.3% of portfolio
Black Rock Inc. New York, NY

2.61M
Shares

$9.65 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

1.81M
Shares

$6.69 Million
0.47% of portfolio
Wells Fargo & Company San Francisco, CA

1.12M
Shares

$4.15 Million
0.0% of portfolio
Platinum Investment Management LTD Sydney Australia 2000, C3

952K
Shares

$3.52 Million
0.16% of portfolio

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $309M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account